Post by
gnote1 on Jan 13, 2021 10:19am
Fundamental Research Dec 2020
BUY Current Price: $0.56 Fair Value: $1.24 Risk*: 4
Revenue beat our expectations. We are revising our 2020 forecast to $58.66M (previously $52.37M), and 2021 forecast to $75.53M (previously $67.44M). • For Q3 and 2020 (9M), EBITDA was -$3.59M and $3.50M, and net losses were $5.85M
retail cannabis sales segment (up 81% YoY) accounted for 60% of Q3 revenue.
Although it is too early to speculate whether D-Pods will gain traction, we consider D-Pods having the ability to further diversify D9’s revenue stream. For conservatism, we are not adding any potential cash flows from this product line, until we have additional details of the product’s effectiveness.
We believe D9 should focus its expansion on the other two markets due to less competition
Sask and Man
Comment by
Jordan1203 on Jan 13, 2021 2:43pm
Any mention of vaccine pods? Still no news on it? Revenue beat their expectations and they are revising their estimates... so that means D9 did like 21 million in q4?!?!
Comment by
gnote1 on Jan 14, 2021 9:24am
Nothing on D-pods, John says it takes time dealing with Government and health organizations. slow process. Looks like Q4 will be over 20 million, guidance coming out by the end of Jan. 3 New stores in Q1, Winnipeg and Rural areas. 11 by year end. Considering M & A to obtain New retail locations if it makes sense. B2B sales with two large projects this year.
Comment by
Northboy44 on Jan 14, 2021 9:26am
See by winnepeg story this morn Manitoba planning to open many new cannibas stores...J A. Is mentioned to be opening three new stores in north winnepegifirst quarter....Do we still have an IR person..no use paying one.. We get more info from gnote1
Comment by
gnote1 on Jan 14, 2021 9:45am
This is the CBC article on Cannabis store expansion, https://www.cbc.ca/news/canada/manitoba/manitoba-cannabis-store-expansion-1.5871398 Forgot to mention, John suggested they are looking at clearing up the Debentures earlier then 2022. Possibly this calender year.